Creode is a personal essay newsletter by a therapeutics researcher covering life sciences, machine learning, and drug discovery. Issues argue for specific strategic priorities, such as using AI and genomics to expand drug targets and reverse declining R&D productivity, and explain the reasoning with historical and conceptual framing.
Website: https://blog.jck.bio
This newsletter covers how to deploy and validate AI in GxP-regulated life sciences settings, using case studies, FDA enforcement analysis and practical frameworks. Readers get guidance on GAMP 5 risk-based validation, model documentation and regulatory compliance for probabilistic AI systems.
Long-form essays on the frontier of biology, covering research institutions, AI-driven drug discovery, and biotech founders. Readers get narrative-driven analysis that connects data, companies, and ideas from the life sciences and biotech investing.
Essays on omnichannel engagement and applied AI in pharma and life sciences, mixing hands-on build write-ups with industry analysis. Readers get practical explanations of how to run coordinated HCP engagement and use generative AI within regulatory constraints.
LatchBio publishes research benchmarks testing whether AI agents can perform bioinformatics and life-science analyses such as omics, oncology decision-making and metagenomics. Each issue announces a new benchmark with results tables, failure-mode breakdowns and design details.
One short email a week with hand-picked newsletters from the index. Free, no spam, unsubscribe anytime.
